CRYO CELL INTERNATIONAL INC (CCEL) Stock Up 6.65% After Q3 2026 Earnings Release

CRYO CELL INTERNATIONAL INC (CCEL) stock registered a positive movement in the latest trading session, moving up by 6.65% following the company's Q3 2026 earnings release. Market participants reviewed the newly disclosed financial figures as the stock reacted to the scheduled corporate updates. The trading session recorded notable price action compared to previous closes as investors processed the quarterly data.

According to the reported metrics for the third quarter of 2026, the market consensus and actual figures outlined specific figures for the period. The reported data indicated an EPS estimate of 0.0306 and a revenue estimate of 7.60 million dollars, providing a benchmark against which the latest period was measured. These figures form the basis of the earnings reaction observed across the trading session for CRYO CELL INTERNATIONAL INC (CCEL).

During the session, CRYO CELL INTERNATIONAL INC (CCEL) opened at $4.04 and experienced an intraday trading range between a low of $3.70 and a high of $4.72. The final recorded price settled at $4.17, reflecting an absolute price change of $0.26 relative to the previous close of $3.91. Market data highlights these specific execution parameters as the equity moved throughout the active hours.

CRYO CELL INTERNATIONAL INC operates within the Health Care sector, categorized under the SEC industry classification of Services-Misc Health & Allied Services, NEC. This classification encompasses specialized operations related to health and allied services within the broader healthcare market. The business activities of CRYO CELL INTERNATIONAL INC (CCEL) align with these specialized health service categories as reflected in official regulatory filings.

Financial metrics for CRYO CELL INTERNATIONAL INC (CCEL) indicate a market capitalization of approximately $33.62 million alongside a trailing twelve-month EPS of -0.3065. The 52-week trading range for the stock spans from a low of $2.72 to a high of $4.90, alongside a 10-day average volume of 0.00757 million. Historical financial statements filed with the SEC show net income figures of $0.4 million for FY2025 and $-9.5 million for FY2024, with total assets recorded at $64.7 million and total liabilities at $77.9 million for the 2025 fiscal year.

Broader market conditions during the period featured a 10-year to 2-year Treasury yield spread of 0.47 based on data from October 8, 2026, alongside a VIX volatility index reading of 15.08 from October 7, 2026. These macroeconomic indicators provide the general financial backdrop against which equities, including CRYO CELL INTERNATIONAL INC (CCEL), traded during the session. Overall market sentiment integrated these interest rate and volatility measurements alongside sector-specific corporate events.

In summary, CRYO CELL INTERNATIONAL INC (CCEL) concluded its trading session with a 6.65% increase, driven by reactions to the Q3 2026 earnings disclosures. Market data captured the intraday range, volume context, and valuation metrics associated with the equity. CRYO CELL INTERNATIONAL INC (CCEL) continues to be monitored by market participants through its ongoing financial disclosures and regulatory filings.

FAQ

Why did CCEL stock move today?

CRYO CELL INTERNATIONAL INC (CCEL) stock moved up by 6.65% following the release of its Q3 2026 earnings report and associated quarterly financial metrics.

What is an earnings report in the context of public companies?

An earnings report is a periodic financial statement issued by publicly traded companies detailing their revenues, expenses, net income, and per-share performance over a specific quarter or fiscal year.